These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20634589)

  • 1. Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature.
    Huang TL
    J Alzheimers Dis; 2010; 21(3):673-90. PubMed ID: 20634589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging.
    Bourre JM
    J Nutr Health Aging; 2005; 9(1):31-8. PubMed ID: 15750663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J
    J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
    Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
    Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary fatty acids intake: possible role in cognitive decline and dementia.
    Solfrizzi V; D'Introno A; Colacicco AM; Capurso C; Del Parigi A; Capurso S; Gadaleta A; Capurso A; Panza F
    Exp Gerontol; 2005 Apr; 40(4):257-70. PubMed ID: 15820606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms.
    Solfrizzi V; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Vendemiale G; Capurso A; Panza F
    Ageing Res Rev; 2010 Apr; 9(2):184-99. PubMed ID: 19643207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish, docosahexaenoic acid and Alzheimer's disease.
    Cunnane SC; Plourde M; Pifferi F; Bégin M; Féart C; Barberger-Gateau P
    Prog Lipid Res; 2009 Sep; 48(5):239-56. PubMed ID: 19362576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of omega-3 fatty acids for memory and cognitive function].
    Waitzberg DL; Garla P
    Nutr Hosp; 2014 Sep; 30(3):467-77. PubMed ID: 25238820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IANA task force on nutrition and cognitive decline with aging.
    Gillette Guyonnet S; Abellan Van Kan G; Andrieu S; Barberger Gateau P; Berr C; Bonnefoy M; Dartigues JF; de Groot L; Ferry M; Galan P; Hercberg S; Jeandel C; Morris MC; Nourhashemi F; Payette H; Poulain JP; Portet F; Roussel AM; Ritz P; Rolland Y; Vellas B
    J Nutr Health Aging; 2007; 11(2):132-52. PubMed ID: 17435956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; Chirico M; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2007 Mar; 55(3):469-70. PubMed ID: 17341255
    [No Abstract]   [Full Text] [Related]  

  • 16. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why?
    Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health?
    Milte CM; Sinn N; Howe PR
    Nutr Rev; 2009 Oct; 67(10):573-90. PubMed ID: 19785689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease.
    Boudrault C; Bazinet RP; Ma DW
    J Nutr Biochem; 2009 Jan; 20(1):1-10. PubMed ID: 18824343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
    Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
    J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited].
    Palmblad J; Eriksdotter-Jönhagen M; Freund-Levi Y; Cederholm T
    Lakartidningen; 2007 Oct 31-Nov 6; 104(44):3268-71. PubMed ID: 18050989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.